The FDA reduced its therapeutic equivalence rating in Accord Healthcare’s tacrolimus oral capsules because of safety concerns, but the generic’s approval remains, the agency said Sept. 19. Tacrolimus ...
Credit: FDA. The BX rating indicates that the data are insufficient to show that the product provides the same therapeutic effect as Prograf. The Food and Drug Administration (FDA) has changed the ...
The 354 subjects were randomly divided into a development (60%) and a validation cohort (40%). The data from the development cohort (212 subjects with 3704 troughs) were used to build the apparent ...
Sequential Oral, Topical Tacrolimus Benefits Dermatitis Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD). (HealthDay News) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results